Clinton Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Clinton Group's GILD Position: Q3 2018 in Review
Clinton Group sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 7,582 shares — an estimated $537K sold.
Clinton Group first reported a position in GILD in Q1 2014 and held it in 15 quarters. The position peaked at $8.21M in Q2 2016. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.
- Clinton Group reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
- Clinton Group sold 7,582 Gilead Sciences shares in Q3 2018, an estimated $537K.
- Clinton Group first reported a position in Gilead Sciences in Q1 2014 and held it in 15 quarters.
- Clinton Group's Gilead Sciences position peaked at $8.21M in Q2 2016.
- 1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.
Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.